Hospital Acquired Infection Control Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Disinfectors, Equipment, Sterilization Equipment, Services, Consumables), By End-use (Hospitals, Clinical Laboratories, others) and Region Forecast 2020-2031  

Hospital Acquired Infection Control Market size was valued at US$ 21.1 billion in 2024 and is expected to reach US$ 33.1 billion by 2031, growing at a significant CAGR of 6.7% from 2025-2031. Hospital acquired infections (HAIs) is a noteworthy security worry for both human services suppliers and the patients. Thinking about bleakness, mortality, expanded length of stay and the cost, endeavors ought to be made to make the healing facilities as protected as conceivable by forestalling such diseases. The hospital-acquired infection control market is very aggressive and comprises of driving pharmaceutical organizations who represent most the pieces of the overall industry. Organizations with restricted experience are creating imaginative answers for control doctor's facility gained diseases. Interests in the assembling to grow generation offices and impressive endeavors to create propelled drugs that can fix hospital-acquired infection control are the key procedures utilized by the market players. To extend the client base, some key organizations are additionally concentrating on launching products with impartial costs that can be productive for the organization and moderate for the patients.

Key Developments

In January 2017, Advanced Sterilization Products propelled STERRAD 100NX System with ALLClear in the U.S and is intending to extend its impression into districts, for example, Europe, Africa and Middle East. This market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.